0001628280-24-020433.txt : 20240503 0001628280-24-020433.hdr.sgml : 20240503 20240503214036 ACCESSION NUMBER: 0001628280-24-020433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240503 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nouri Alaleh CENTRAL INDEX KEY: 0001599418 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 24915331 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 6502329832 MAIL ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 wk-form4_1714786824.xml FORM 4 X0508 4 2024-05-03 0 0001588978 PROCEPT BioRobotics Corp PRCT 0001599418 Nouri Alaleh C/O PROCEPT BIOROBOTICS CORPORATION 150 BAYTECH DRIVE SAN JOSE CA 95134 0 1 0 0 EVP, CLO, CORP. SEC. 0 Common Stock 2024-05-03 4 M 0 1467 4.56 A 63939 D Common Stock 2024-05-03 4 M 0 3965 5.18 A 67904 D Common Stock 2024-05-03 4 M 0 25000 7.27 A 92904 D Common Stock 2024-05-03 4 S 0 391 60.84 D 92513 D Common Stock 2024-05-03 4 S 0 1536 61.28 D 90977 D Common Stock 2024-05-03 4 S 0 13935 62.79 D 77042 D Common Stock 2024-05-03 4 S 0 14437 63.38 D 62605 D Common Stock 2024-05-03 4 S 0 133 64.04 D 62472 D Stock Option (Right to Buy) 4.56 2024-05-03 4 M 0 1467 0 D 2029-12-11 Common Stock 1467 12230 D Stock Option (Right to Buy) 5.18 2024-05-03 4 M 0 3965 0 D 2030-08-08 Common Stock 3965 16160 D Stock Option (Right to Buy) 7.27 2024-05-03 4 M 0 25000 0 D 2031-06-21 Common Stock 25000 32894 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.02 to $64.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri 2024-05-03